Cefoperazone: Spectrum of Antibacterial Activity and Disc Diffusion Testing C. ThornsberryR. N. Jones Session I 15 November 2012 Pages: 3 - 12
Susceptibility of Penicillin-insensitive Pneumococci to Newer Cephalosporins David Hansman Session I 15 November 2012 Pages: 13 - 14
Comparison of the Activity of Cefoperazone, Cefuroxime and Cefoxitin against Gram-negative Bacilli and Synergy Studies with Cefoperazone and Ticarcillin Helen M. MilesMara CarsonE. R. Pavillard Session I 15 November 2012 Pages: 15 - 19
The Role of the Laboratory in the Planned Use of Cefoperazone for the Treatment of Difficult Pseudomonas Infections Malcolm McDonaldHelen MilesMara Carson Session I 15 November 2012 Pages: 20 - 26
Sensitivity of Bacterial Isolates to Cefoperazone Barbara A. PeddieVicki BishopRoss R. Bailey Session I 15 November 2012 Pages: 27 - 28
Susceptibility of Clinical Isolates to Cefoperazone D. A. Bremner Session I 15 November 2012 Pages: 29 - 31
Pharmacokinetics of Cefoperazone: A Review William A. CraigAndreas U. Gerber Session II 15 November 2012 Pages: 35 - 45
Serum and Urine Concentrations of Cefoperazone in Severe Chronic Renal Failure Ross R. BaileyBarbara PeddieElspeth Blake Session II 15 November 2012 Pages: 46 - 51
Anomalous Effect of Serum on the Antimicrobial Activity of Cefoperazone S. D. R. LangG. L. CameronP. R. Mullins Session II 15 November 2012 Pages: 52 - 59
Potential Value of Cefoperazone in Bacterial Meningitis: Experimental Studies David T. DurackJohn R. Perfect Session II 15 November 2012 Pages: 60 - 64
Cefoperazone in Klebsiella Meningitis: A Case Report R. B. Ellis-PeglerS. D. R. Lang Session III 15 November 2012 Pages: 69 - 71
A Clinical Trial with Cefoperazone in Pneumonia and Pyelonephritis Seung Chull ParkJ. H. LeeE. S. Sohn Session III 15 November 2012 Pages: 72 - 75
Cefoperazone in the Treatment of Severe or Complicated Infections Ross R. BaileyBarbara PeddieJ. Reddy Session III 15 November 2012 Pages: 76 - 86
Clinical Studies with Cefoperazone in the Treatment of Bacterial Infections in Surgical Practice Jin-Pok KimSang-Joon Kim Session III 15 November 2012 Pages: 87 - 93
Cefoperazone in Lower Respiratory Tract Infections C. J. WoodsR. B. Ellis-Pegler Session IV 15 November 2012 Pages: 96 - 99
Clinical Experience with Cefoperazone in Biliary Tract Infections Keimei Mashimo Session IV 15 November 2012 Pages: 100 - 107
Worldwide Clinical Experience with Cefoperazone Andreas U. GerberWilliam A. Craig Session IV 15 November 2012 Pages: 108 - 118